There was no statistically significant relationship between the expression of REV1 and the prognosis of breast cancer patients [distant metastasis-free survival (DMFS), OS and PPS], gastric cancer (FP) and ovarian cancer (OS and PFS) (Supplementary Figure S1). This evidence concerns the gene REV1 and ovarian carcinoma.